1)ITIM免疫受体酪氨酸抑制基序
2)immunoreceptor tyrosine-based inhibitory motif(ITIM)免疫受体酪氨酸相关的抑制性基序(ITIM)
3)immunoreceptor tyrosine-based inhibitory motifs免疫受体酪氨酸相关的抑制性基序
4)Immunoreceptor tyrosine-based activation motif免疫受体酪氨酸活化基序
5)ITAM免疫酪氨酸受体激活基序
1.The authors propose a quantitative model for the interaction of TCR and its ligand in T cell activation relying on the two step activation of ITAM.将T细胞受体 (TCR)的活性与免疫酪氨酸受体激活基序 (ITAM)活性联系起来 ,深入考虑了TCR与其配体的亲和力和离解率 。
6)Receptor tyrosine kinase inhibitor受体酪氨酸激酶抑制剂
1.Objective To explore the protective role of the receptor tyrosine kinase inhibitor in chondrocyte in vitro.目的通过对体外培养软骨细胞的实验研究,探寻受体酪氨酸激酶抑制剂对软骨细胞在细胞分子水平的影响及其可能机制。
英文短句/例句
1.Advances in the inhibitors of FLT-3 receptor tyrosine kinaseFLT-3受体酪氨酸激酶抑制剂的研究进展
2.Progress in research of multi-targeted inhibitors of receptor tyrosine kinase多靶点受体酪氨酸激酶抑制剂的研究进展
3.The inhibitor of VEGF receptor tyrosine kinase was introduced in detail.详细介绍了VEGF受体酪氨酸激酶抑制剂的研究进展。
4.The Effect of Receptor Tyrosine Kinase Inhibitor on Repair Tissue in Chondrocyte and Osteoarthritis Cartilage;受体酪氨酸激酶抑制剂在软骨修复中的作用研究
5.The Experimental Study on the Effect of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor on Polycystic Kidney Disease;表皮生长因子受体酪氨酸激酶抑制剂治疗多囊肾病的实验研究
6.Study of 4-AnilinoquinazoIines as Inhibitors of Tyrosine Kinase of the Epidermal Growth Factor Receptor;4-苯胺基喹唑啉类表皮生长因子受体酪氨酸激酶抑制剂的研究
7.Establishment of high throughput screening model for epidermal growth factor receptor tyrosine kinase inhibitor表皮生长因子受体酪氨酸激酶抑制剂高通量筛选模型的建立
8.The Therapeutic Effect of VEGF and PDGFB Receptor Tyrosine Kinases Inhibitors in Mice Corneal Angiogenesis;VEGF和PDGFB受体酪氨酸激酶抑制剂对小鼠角膜新生血管抑制作用的实验研究
9.The Effects of Combined Administration of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and Cytotoxic Drugs in Different Tumor Cell Lines表皮生长因子受体酪氨酸激酶抑制剂联合化疗对不同肿瘤细胞株的作用
10.Project Epidermal Growth Factor Receptor Tyrosine Protein Kinase Inhibitor Screen Model;表皮生长因子受体酪氨酸蛋白激酶抑制剂筛选模型建立
11.Protein Tyrosine Kinase Inhibitor Genistein to Suppress Invasion of Human Lung Adenocarcinoma Cell Line A549 in vitro蛋白酪氨酸激酶抑制剂Genistein抑制肺癌细胞A549体外侵袭作用的研究
12.Metabolite identification of a novel antineoplastic of tyrosine kinase inhibitor,flumatinib,in chronic myelocytic leukemia patients酪氨酸激酶抑制剂抗肿瘤新药氟马替尼在人体内的代谢产物研究
13.Multi-targeted protein tyrosine kinase inhibitor:research advances多靶点蛋白酪氨酸激酶抑制剂的研究进展
14.Advances in the research of multi-target tyrosine kinase inhibitors多靶点抗肿瘤酪氨酸激酶抑制剂的研究开发
15.Effect of EGFR-TKI on Axonal Regeneration of Rabbit Facial Nerve in Regeneration Chamber: An Experimental Study;表皮生长因子受体酪氨酸酶抑制剂促进面神经再生的实验研究
16.Screen the Inhibitors of Protein Tyrosine Phosphatase 1B;蛋白质酪氨酸磷酸酶1B抑制剂的筛选
17.Synthesis and inhibition activity of 3-substituted indolin-2-ones as inhibitors of VEGFR-2 tyrosine kinaseVEGFR-2酪氨酸激酶抑制剂3-取代吲哚-2-酮的合成及抑制活性
18.Mechanism of drug resistance for chronic myeloid leukemia to BCR-ABL tyrosine kinase inhibitor慢性粒细胞白血病对BCR-ABL酪氨酸激酶靶向抑制剂的耐药机制
相关短句/例句
immunoreceptor tyrosine-based inhibitory motif(ITIM)免疫受体酪氨酸相关的抑制性基序(ITIM)
3)immunoreceptor tyrosine-based inhibitory motifs免疫受体酪氨酸相关的抑制性基序
4)Immunoreceptor tyrosine-based activation motif免疫受体酪氨酸活化基序
5)ITAM免疫酪氨酸受体激活基序
1.The authors propose a quantitative model for the interaction of TCR and its ligand in T cell activation relying on the two step activation of ITAM.将T细胞受体 (TCR)的活性与免疫酪氨酸受体激活基序 (ITAM)活性联系起来 ,深入考虑了TCR与其配体的亲和力和离解率 。
6)Receptor tyrosine kinase inhibitor受体酪氨酸激酶抑制剂
1.Objective To explore the protective role of the receptor tyrosine kinase inhibitor in chondrocyte in vitro.目的通过对体外培养软骨细胞的实验研究,探寻受体酪氨酸激酶抑制剂对软骨细胞在细胞分子水平的影响及其可能机制。
延伸阅读
酪氨酸蛋白激酶抑制剂分子式：CAS号：性质：一类能抑制蛋白质酪氨酸激酶活性的化合物。酪氨酸蛋白激酶能特异性地将磷酸根转移到蛋白质的酪氨酸残基上使其磷酸化，是许多配体活化的生长因子受体和一些癌基因产物，在肿瘤组织中含量高。酪氨酸蛋白激酶抑制剂可作为ATP与酪氨酸蛋白激酶结合的竞争性抑制剂，也可作为酪氨酸的类似物阻断表皮生长因子受体的肽位点和酪氨酸蛋白激酶的编码，抑制细胞增殖，可望开发为抗肿瘤药物，但对完整细胞没有表现出选择性。
